Willingness to pay for drugs in future national health financing scheme among Malaysian population

Research output: Contribution to journalArticle

Abstract

Escalating of healthcare cost is a global healthcare challenges in most of the countries. Inline with the increasing of disease prevalence, there will be escalating of drugs expenditures. In Malaysia, the drug expenditures is keeps increasing which is in 2008, Government spent RM1, 510 million for the drug purchase. Since Malaysia has still in progress of implementing the compulsory National Health Financing Scheme (NHFS), most of these expenditures are still highly subsidized by the government. Therefore, Malaysia is in planning to develop a new national health financing scheme to support the existing health financing policy. It is essential to identify public willingness to pay for drugs in National Health Financing Scheme to ensure the new implemented policy will be benefit the government as well as the patients. In conclusion, health care financing is the most essential component in the achievement of health improvement. The level of health care financing may influences the accessibility to human resources, medical supplies and delivery of health care facilities as well as quality of health services.

Original languageEnglish
Pages (from-to)271-278
Number of pages8
JournalWorld Applied Sciences Journal
Volume30
Issue number3
DOIs
Publication statusPublished - 2014

Fingerprint

Healthcare Financing
Malaysia
Health Expenditures
Pharmaceutical Preparations
Population
Delivery of Health Care
Health Facilities
Health Policy
Health Care Costs
Health Status
Health Services
Health

Keywords

  • Contingent Valuation Method
  • National Health Insurance
  • Willingness-to-pay

ASJC Scopus subject areas

  • General

Cite this

@article{8a8bad9d02454bbda73cf404d439d8ed,
title = "Willingness to pay for drugs in future national health financing scheme among Malaysian population",
abstract = "Escalating of healthcare cost is a global healthcare challenges in most of the countries. Inline with the increasing of disease prevalence, there will be escalating of drugs expenditures. In Malaysia, the drug expenditures is keeps increasing which is in 2008, Government spent RM1, 510 million for the drug purchase. Since Malaysia has still in progress of implementing the compulsory National Health Financing Scheme (NHFS), most of these expenditures are still highly subsidized by the government. Therefore, Malaysia is in planning to develop a new national health financing scheme to support the existing health financing policy. It is essential to identify public willingness to pay for drugs in National Health Financing Scheme to ensure the new implemented policy will be benefit the government as well as the patients. In conclusion, health care financing is the most essential component in the achievement of health improvement. The level of health care financing may influences the accessibility to human resources, medical supplies and delivery of health care facilities as well as quality of health services.",
keywords = "Contingent Valuation Method, National Health Insurance, Willingness-to-pay",
author = "{Siti Nurul Akma}, Ahmad and {Wan Puteh}, {Sharifa Ezat} and Aizuddin, {Azimatun Noor}",
year = "2014",
doi = "10.5829/idosi.wasj.2014.30.03.2597",
language = "English",
volume = "30",
pages = "271--278",
journal = "World Applied Sciences Journal",
issn = "1818-4952",
publisher = "International Digital Organization for Scientific Information",
number = "3",

}

TY - JOUR

T1 - Willingness to pay for drugs in future national health financing scheme among Malaysian population

AU - Siti Nurul Akma, Ahmad

AU - Wan Puteh, Sharifa Ezat

AU - Aizuddin, Azimatun Noor

PY - 2014

Y1 - 2014

N2 - Escalating of healthcare cost is a global healthcare challenges in most of the countries. Inline with the increasing of disease prevalence, there will be escalating of drugs expenditures. In Malaysia, the drug expenditures is keeps increasing which is in 2008, Government spent RM1, 510 million for the drug purchase. Since Malaysia has still in progress of implementing the compulsory National Health Financing Scheme (NHFS), most of these expenditures are still highly subsidized by the government. Therefore, Malaysia is in planning to develop a new national health financing scheme to support the existing health financing policy. It is essential to identify public willingness to pay for drugs in National Health Financing Scheme to ensure the new implemented policy will be benefit the government as well as the patients. In conclusion, health care financing is the most essential component in the achievement of health improvement. The level of health care financing may influences the accessibility to human resources, medical supplies and delivery of health care facilities as well as quality of health services.

AB - Escalating of healthcare cost is a global healthcare challenges in most of the countries. Inline with the increasing of disease prevalence, there will be escalating of drugs expenditures. In Malaysia, the drug expenditures is keeps increasing which is in 2008, Government spent RM1, 510 million for the drug purchase. Since Malaysia has still in progress of implementing the compulsory National Health Financing Scheme (NHFS), most of these expenditures are still highly subsidized by the government. Therefore, Malaysia is in planning to develop a new national health financing scheme to support the existing health financing policy. It is essential to identify public willingness to pay for drugs in National Health Financing Scheme to ensure the new implemented policy will be benefit the government as well as the patients. In conclusion, health care financing is the most essential component in the achievement of health improvement. The level of health care financing may influences the accessibility to human resources, medical supplies and delivery of health care facilities as well as quality of health services.

KW - Contingent Valuation Method

KW - National Health Insurance

KW - Willingness-to-pay

UR - http://www.scopus.com/inward/record.url?scp=84894504791&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894504791&partnerID=8YFLogxK

U2 - 10.5829/idosi.wasj.2014.30.03.2597

DO - 10.5829/idosi.wasj.2014.30.03.2597

M3 - Article

VL - 30

SP - 271

EP - 278

JO - World Applied Sciences Journal

JF - World Applied Sciences Journal

SN - 1818-4952

IS - 3

ER -